Title: Conformers of a novel lipopeptide antibiotic, Kannurin inhibits SARS-Cov2 replication via interfering with RNA-dependent-RNA polymerase activation and function

Authors: H. Shabeer Ali; P. Prajosh; K. Sreejith; M. Divya Lakshmanan

Addresses: Division of Molecular Parasitology and Immunology, CSIR-Central Drug Research Institute, Lucknow, Uttarpradesh, 226031, India ' Department of Biotechnology and Microbiology, Kannur University, Kerala, 670 661, India ' Department of Biotechnology and Microbiology, Kannur University, Kerala, 670 661, India ' Molecular Biology Division, Yenepoya Research Centre, Yenepoya (Deemed to be University), Deralakatte, Mangalore, 575018, Karnataka, India

Abstract: The key component 'nsp12' of RNA-dependent-RNA polymerase of Corona virus is considered as a primary target for drug intervention purposes. The broad spectrum antimicrobial lipopeptide Kannurin revealed favourable interactions against nsp12 in preliminary in silico experiment. Among the different target sites on nsp12 selected for docking study, the cyclic form of Kannurin was found to interact with the residues Phe 407, Leu 544 and Lys 511 present in the finger subdomain of nsp12 that are facilitating the binding of nsp7 and nsp8 cofactors. Hence it is proposed that Kannurin can act by inhibiting the binding of cofactors with nsp12 and ultimately leading to its inactivation. The second mechanism is by the interaction of linear form of Kannurin with the palm subdomain cavity, specifically with the residue Arg 555 that involved in receiving the incoming nucleotides during replication. The mechanism is closely related to the action of 'Remdesivir'.

Keywords: SARS-COV; Kannurin; lipopeptide; nsp12; nsp7; nsp8.

DOI: 10.1504/IJCBDD.2021.118826

International Journal of Computational Biology and Drug Design, 2021 Vol.14 No.4, pp.251 - 260

Received: 11 Jun 2020
Accepted: 09 Apr 2021

Published online: 31 Oct 2021 *

Full-text access for editors Access for subscribers Purchase this article Comment on this article